Consolidated Statement of Shareholders' Equity Consolidated Statement of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Parent [Member]	Noncontrolling Interest [Member]
Shareholders' Equity at Feb. 01, 2014	$ 477,362	$ 434	$ 131,398	$ 16,676	$ 328,191	$ 476,699	$ 663
Common stock shares outstanding at Feb. 01, 2014	43,378,279
Net earnings	$ 82,943				82,850	82,850	93
Foreign currency translation adjustment	(3,145)			(3,101)		(3,101)	(44)
Unrealized loss on derivative financial instruments, net of tax	(514)			(514)		(514)
Pension and other postretirement benefit adjustments, net of tax	(10,349)			(10,349)		(10,349)
Comprehensive income	68,935					68,886	49
Dividends ($0.28 per share)	$ (12,237)				(12,237)	(12,237)
Shares repurchased during period under share repurchase program	0
Shares issued under employee and director benefit and restricted stock plans	373,752
Stock issued under employee and director benefit and restricted stock plans	$ 443	3	440			443
Excess tax benefit related to share-based plans	929		929			929
Share-based compensation expense	6,190		6,190			6,190
Shareholders' Equity at Jan. 31, 2015	$ 541,622	437	138,957	2,712	398,804	540,910	712
Common stock shares outstanding at Jan. 31, 2015	43,752,031
Net earnings	$ 81,824				81,479	81,479	345
Foreign currency translation adjustment	(224)			(155)		(155)	(69)
Unrealized loss on derivative financial instruments, net of tax	168			168		168
Pension and other postretirement benefit adjustments, net of tax	(8,589)			(8,589)		(8,589)
Comprehensive income	73,179					72,903	276
Dividends ($0.28 per share)	$ (12,253)				(12,253)	(12,253)
Shares repurchased during period under share repurchase program	(151,500)
Treasury Stock, Value, Acquired, Cost Method	$ (4,921)	(2)	(4,919)			(4,921)
Shares issued under employee and director benefit and restricted stock plans	59,682
Stock issued under employee and director benefit and restricted stock plans	$ (5,297)	2	(5,299)			(5,297)
Excess tax benefit related to share-based plans	2,651		2,651			2,651
Share-based compensation expense	7,491		7,491			7,491
Shareholders' Equity at Jan. 30, 2016	$ 602,472	437	138,881	(5,864)	468,030	601,484	988
Common stock shares outstanding at Jan. 30, 2016	43,660,213
Net earnings	$ 66,086				65,658	65,658	428
Foreign currency translation adjustment	1,045			1,092		1,092	(47)
Unrealized loss on derivative financial instruments, net of tax	(934)			(934)		(934)
Pension and other postretirement benefit adjustments, net of tax	(24,728)			(24,728)		(24,728)
Comprehensive income	41,469					41,088	381
Dividends ($0.28 per share)	$ (12,104)				(12,104)	(12,104)
Shares repurchased during period under share repurchase program	(900,000)
Treasury Stock, Value, Acquired, Cost Method	$ (23,139)	(9)	(23,130)			(23,139)
Shares issued under employee and director benefit and restricted stock plans	203,006
Stock issued under employee and director benefit and restricted stock plans	$ (4,188)	2	(4,190)			(4,188)
Excess tax benefit related to share-based plans	2,251		2,251			2,251
Share-based compensation expense	7,725		7,725			7,725
Shareholders' Equity at Jan. 28, 2017	$ 614,486	$ 430	$ 121,537	$ (30,434)	$ 521,584	$ 613,117	$ 1,369
Common stock shares outstanding at Jan. 28, 2017	42,963,219